Prognostic role of DDR genes mutations and their association with the sensitivity of Olaparib in prostate cancer patients

2021 ◽  
Author(s):  
Xinglin Chen ◽  
◽  
Dong Zhang ◽  
Xinchi Xu ◽  
Yuang Wei ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Prognostic Role

LB22 Prognostic role of plasma chromogranin a levels in prostate cancer patients with hormone refractory disease

2004 ◽  
Vol 3 (2) ◽  
pp. 237
Author(s):  
C. Terrone ◽  
R. Tarabuzzi ◽  
C. Cracco ◽  
S. Guercio ◽  
M. Poggio ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Chromogranin A ◽  
Refractory Disease ◽  
Prognostic Role ◽  
Hormone Refractory

Prognostic role of plasma chromogranin A levels in prostate cancer patients with hormone refractory disease

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 9563-9563
Author(s):  
A. Mosca ◽  
A. Berruti ◽  
M. Tucci ◽  
F. Vana ◽  
R. Bitossi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Chromogranin A ◽  
Refractory Disease ◽  
Prognostic Role ◽  
Hormone Refractory

Prognostic role of neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with docetaxel.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e16050-e16050
Author(s):  
Atike Pinar ◽  
Ahmet Ozveren ◽  
Zeki Gokhan Surmeli ◽  
Ulus Ali Sanli ◽  
Ruchan Uslu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Neutrophil To Lymphocyte Ratio ◽  
Castration Resistant Prostate Cancer ◽  
Prognostic Role ◽  
Lymphocyte Ratio ◽  
Castration Resistant

939 PROGNOSTIC ROLE OF SERUM TESTOSTERONE LEVELS IN PROSTATE CANCER PATIENTS DURING ANDROGEN-DEPRIVATION THERAPY

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Francesco Porpiglia ◽  
Cristian Fiori ◽  
Valentina Bertaglia ◽  
Marcello Tucci ◽  
Emiliano Aroasio ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Androgen Deprivation Therapy ◽  
Serum Testosterone ◽  
Androgen Deprivation ◽  
Prognostic Role ◽  
Testosterone Levels

The prognostic role of immunohistochemical chromogranin a expression in prostate cancer patients is significantly modified by androgen-deprivation therapy

The Prostate ◽  
2010 ◽  
Vol 70 (7) ◽  
pp. 718-726 ◽  
Author(s):  
Alfredo Berruti ◽  
Enrico Bollito ◽  
Cecilia M. Cracco ◽  
Marco Volante ◽  
Giovannino Ciccone ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Androgen Deprivation Therapy ◽  
Chromogranin A ◽  
Androgen Deprivation ◽  
Prognostic Role

Prognostic role of plasma chromogranin A levels in prostate cancer patients with hormone refractory disease

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 9563-9563
Author(s):  
A. Mosca ◽  
A. Berruti ◽  
M. Tucci ◽  
F. Vana ◽  
R. Bitossi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Chromogranin A ◽  
Refractory Disease ◽  
Prognostic Role ◽  
Hormone Refractory

Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide

2020 ◽  
Vol 72 (6) ◽  
Author(s):  
Consuelo Buttigliero ◽  
Marcello Tucci ◽  
Cristina Sonetto ◽  
Francesca Vignani ◽  
Rosario F. Di Stefano ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Abiraterone Acetate ◽  
Castration Resistant Prostate Cancer ◽  
Prognostic Role ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document